BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/26/2021 11:20:59 AM | Browse: 457 | Download: 1110
 |
Received |
|
2021-01-15 17:45 |
|
Peer-Review Started |
|
2021-01-15 17:47 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-01-31 02:39 |
|
Revised |
|
2021-02-12 18:23 |
|
Second Decision |
|
2021-06-07 12:31 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-06-07 13:22 |
|
Articles in Press |
|
2021-06-07 13:22 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-07-12 03:11 |
|
Typeset the Manuscript |
|
2021-07-22 03:07 |
|
Publish the Manuscript Online |
|
2021-07-26 11:20 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Gastrointestinal and hepatic diseases during COVID-19 pandemic: Manifestations, mechanism and management
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Dina Zakaria Mohamed, Mai El-Sayed Ghoneim, Sally El-Sayed Abu-Risha, Ramy Ahmed Abdelsalam and Mohamed Abdelhalem Farag |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dina Zakaria Mohamed, MSc, Assistant Lecturer, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, El-Geish St., Tanta, El-Gharbia Governorate, Arab Republic of Egypt, Tanta 31511, Egypt. m_halem1986@yahoo.com |
| Key Words |
COVID-19; Angiotensin-converting enzyme 2; Gastrointestinal; Inflammatory bowel disease; Liver; Management |
| Core Tip |
The coronavirus disease 2019 (COVID-19) pandemic has affected millions worldwide, with high lethality. In addition to typical respiratory symptoms of COVID-19, gastrointestinal symptoms and hepatic harm have been frequently shown during COVID-19. The main purpose of this article is to focus on the manifestations, mechanisms, and management of the gastrointestinal tract and liver that occurred during COVID-19 course. Therefore, physicians must not undervalue the digestive symptoms during COVID-19 infection and rapidly adjust the treatment options for COVID-19 patients during gastrointestinal symptoms and liver enzyme abnormalities. |
| Publish Date |
2021-07-26 11:20 |
| Citation |
Mohamed DZ, Ghoneim MES, Abu-Risha SES, Abdelsalam RA, Farag MA. Gastrointestinal and hepatic diseases during COVID-19 pandemic: Manifestations, mechanism and management. World J Gastroenterol 2021; 27(28): 4504-4535 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i28/4504.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i28.4504 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
